rYojbaba Co Ltd
RYOJIndustrials·Consulting Services·Japan·Nano·NASD·Nov 11 • 3:56 PM ET
2.57-0.04 (-1.53%)
2026-11-12 02:26 CET
Market cap
30.15 USD m
Revenue, TTM
0.06 USD m
Net income, TTM
0.00 USD m
Free cash flow, TTM
- USD m
EPS diluted, TTM
0.00
P/E
25700.00
Price
RYOJ against its 20, 50 and 200-day averages2050200
68.3% under the 52-week high of 8.10 on 22 May 2026. 52-week low 1.56 on 21 May 2026. Last 15 sessions, 29.0% high to low
Volume 0.07× normal · the line is the 50-bar volume average
Profile
RYOJ52-week range, 15% of the way up
1.568.10
rYojbaba Co., Ltd. engages in providing consulting and health services to improve and restore physical and mental health diminished by work-related stress. It operates through the Labor Consulting Services and Health Services segments. The Labor Consulting Services segment provides labor and corporate consulting services to foster constructive employment relationships between companies and employees. The Health Services segment provides health services through osteopathic clinics and osteopathic beauty salons to alleviate physical ailments primarily created by work related stress. The company was founded by Masataka Sakai on January 5, 2015 and is headquartered in Fukuoka, Japan.
| Employees | 313 |
|---|---|
| IPO | Aug 14, 2025 |
| Beta | 4.79 |
| ATR, 14d | 0.32 |
| Rel volume | 0.07 |
| Short float | 0.52% |
| Insider own | 80.05% |
| Inst own | 0.02% |
Snapshot
6 groupsValuation
| Index | - |
|---|---|
| Market Cap | 29.69M |
| Enterprise Value | 29.71M |
| Income | 0.00M |
| Sales | 0.06M |
| Book/sh | 0.00 |
| Cash/sh | 0.00 |
| Dividend Est. | - |
| Dividend TTM | - |
| Dividend Ex-Date | - |
| Dividend Gr. 3/5Y | - - |
| Payout | 0.00% |
| Employees | 313 |
| IPO | Aug 14, 2025 |
Ratios
| P/E | 25700.00 |
|---|---|
| Forward P/E | - |
| PEG | - |
| P/S | 494.80 |
| P/B | 762.61 |
| P/C | 742.20 |
| P/FCF | - |
| EV/EBITDA | - |
| EV/Sales | 495.13 |
| Quick Ratio | 2.68 |
| Current Ratio | 2.70 |
| Debt/Eq | 1.50 |
| LT Debt/Eq | 1.25 |
| Option/Short | No / Yes |
Earnings
| EPS (ttm) | 0.00 |
|---|---|
| EPS next Y | - |
| EPS next Q | - |
| EPS this Y | - |
| EPS next Y | - |
| EPS next 5Y | - |
| EPS past 3/5Y | - - |
| Sales past 3/5Y | -7.84% - |
| EPS Y/Y TTM | -87.50% |
| Sales Y/Y TTM | -18.29% |
| EPS Q/Q | -133.33% |
| Sales Q/Q | -34.27% |
| Earnings | - |
| EPS/Sales Surpr. | - - |
Ownership
| Insider Own | 80.05% |
|---|---|
| Insider Trans | 0.00% |
| Inst Own | 0.02% |
| Inst Trans | -27.13% |
| ROA | 0.79% |
| ROE | 3.05% |
| ROIC | 0.97% |
| Gross Margin | 26.56% |
| Oper. Margin | -7.91% |
| Profit Margin | 1.34% |
| SMA20 | 2.49% |
| SMA50 | -21.26% |
| SMA200 | -18.27% |
| Trades | - |
Technical
| Shs Outstand | 11.55M |
|---|---|
| Shs Float | 2.30M |
| Short Float | 0.52% |
| Short Ratio | 0.16 |
| Short Interest | 0.01M |
| 52W High | 8.10 -68.27% |
| 52W Low | 1.56 64.74% |
| Volatility | 9.01% 16.93% |
| ATR (14) | 0.32 |
| RSI (14) | 45.45 |
| Beta | 4.79 |
| Rel Volume | 0.07 |
| Avg Volume | 75.92K |
| Volume | 5,538 |
Performance
| Perf Week | -3.20% |
|---|---|
| Perf Month | -6.55% |
| Perf Quarter | -44.73% |
| Perf Half Y | 39.85% |
| Perf YTD | -15.74% |
| Perf Year | -46.35% |
| Perf 3Y | - |
| Perf 5Y | - |
| Perf 10Y | - |
| Recom | - |
| Target Price | - |
| Prev Close | 2.61 |
| Price | 2.57 |
| Change % | -1.53% |
Peers
Mkt cap| Ticker | Company | Mkt cap |
|---|---|---|
| RGP | Resources Connection Inc | 95.08M |
| SBC | SBC Medical Group Holdings Inc | 538.92M |
| PPHC | Public Policy Holding Company Inc | 335.70M |
| FORR | Forrester Research Inc | 163.96M |
| CRAI | CRA International Inc | 1.26B |
| HURN | Huron Consulting Group Inc | 2.65B |
| MRM | MEDIROM Healthcare Technologies Inc ADR | 2.19M |
| ADBT | Advasa Holdings Inc | 49.59M |
| ASUR | Asure Software Inc | 313.17M |
| LFS | Leifras Co Ltd ADR | 48.40M |
Quarterly earnings
actual against estimate| Period | Reported | EPS act | EPS est | EPS rep | Sales act | Sales est | Analysts |
|---|---|---|---|---|---|---|---|
| No quarterly earnings. | |||||||
Annual earnings
| Period | EPS act | EPS est | EPS rep | Sales act | Sales est |
|---|---|---|---|---|---|
| No annual earnings. | |||||
Estimate revisions
last 14 periods| Period | Type | Date | Estimates | Up | Down | Mean | Low | High |
|---|---|---|---|---|---|---|---|---|
| No estimate revisions. | ||||||||
Estimate history
| EPS, annual | 0 | 0.001 | 0.001 | 0 |
|---|---|---|---|---|
| Period | 2022 | 2023 | 2024 | 2025 |
| EPS, quarterly | ||||
| Period | ||||
| Sales, annual | 0.08 | 0.078 | 0.076 | 0.062 |
| Period | 2022 | 2023 | 2024 | 2025 |
| Sales, quarterly | ||||
| Period | ||||
| Shares, annual | 10 | 11.25 | 11.25 | 11.55 |
| Period | 2022 | 2023 | 2024 | 2025 |
| Shares, quarterly | ||||
| Period |
Income statement, annual
| Metric | TTM | 2025FY | 2024FY | 2023FY | 2022FY |
|---|---|---|---|---|---|
| Total Revenue | 0.06 | 0.06 | 0.08 | 0.08 | 0.08 |
| Cost of Goods Sold Incl. D&A | 0.05 | 0.05 | 0.05 | 0.05 | 0.06 |
| Gross Profit | 0.02 | 0.02 | 0.03 | 0.03 | 0.02 |
| Selling, General and Administrative Excl. Other | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 |
| Other Operating Expense | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Income | -0.00 | -0.01 | 0.01 | 0.01 | -0.00 |
| Interest Expense | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Unusual Expense | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income Before Taxes | -0.00 | -0.00 | 0.01 | 0.01 | -0.00 |
| Income Taxes | -0.00 | -0.00 | 0.00 | 0.00 | -0.00 |
| Consolidated Net Income | 0.00 | 0.00 | 0.01 | 0.01 | -0.00 |
| Net Income From Continuing Operations | 0.00 | 0.00 | 0.01 | 0.01 | -0.00 |
| Net Income | 0.00 | 0.00 | 0.01 | 0.01 | -0.00 |
| EPS (Recurring) | 0.00 | 0.00 | 0.00 | 0.00 | -0.00 |
| EPS (Basic, Before Extraordinaries) | 0.00 | 0.00 | 0.00 | 0.00 | -0.00 |
| EPS (Diluted) | 0.00 | 0.00 | 0.00 | 0.00 | -0.00 |
| EBITDA | -0.00 | -0.00 | 0.02 | 0.01 | -7E-05 |
| Non-Operating Income (Expense) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other After Tax Adjustments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Stock Option Compensation Expense | - | 0.00 | - | - | - |
| Price To Earnings Ratio | 26,100.00 | 26,100.00 | 3,987.50 | - | - |
| Price To Sales Ratio | 563.96 | 564.51 | - | - | - |
| Gross Margin | 26.56 | 26.47 | 38.33 | 33.53 | 18.98 |
| Operating Margin | -7.91 | -8.09 | 16.07 | 11.91 | -2.87 |
| Net Margin | 1.34 | 1.28 | 11.51 | 7.03 | -4.32 |
| Shares Outstanding | 11.55 | 11.55 | 11.25 | 11.25 | 10.00 |
| Market Capitalization | 30.15 | 30.15 | 35.89 | - | - |
Income statement, quarterly
| Metric | 2025S2 | 2025S1 | 2024S2 | 2024S1 | 2023S2 | 2023S1 |
|---|---|---|---|---|---|---|
| Total Revenue | 0.03 | 0.03 | 0.04 | 0.03 | 0.03 | 0.04 |
| Cost of Goods Sold Incl. D&A | 0.02 | 0.02 | 0.03 | 0.02 | 0.02 | 0.03 |
| Gross Profit | 0.00 | 0.01 | 0.02 | 0.01 | 0.01 | 0.02 |
| Selling, General and Administrative Excl. Other | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 |
| Other Operating Expense | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Income | -0.01 | 0.00 | 0.01 | 0.00 | 0.00 | 0.01 |
| Interest Expense | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Unusual Expense | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income Before Taxes | -0.01 | 0.00 | 0.01 | 0.00 | 0.00 | 0.01 |
| Income Taxes | -0.01 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Consolidated Net Income | -0.00 | 0.00 | 0.01 | 0.00 | 0.00 | 0.00 |
| Net Income From Continuing Operations | -0.00 | 0.00 | 0.01 | 0.00 | 0.00 | 0.00 |
| Net Income | -0.00 | 0.00 | 0.01 | 0.00 | 0.00 | 0.00 |
| EPS (Recurring) | -0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS (Basic, Before Extraordinaries) | -0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS (Diluted) | -0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| EBITDA | -0.01 | 0.00 | 0.01 | 0.01 | 0.00 | 0.01 |
| Non-Operating Income (Expense) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Price To Earnings Ratio | 25,700.00 | 3,987.50 | - | - | - | - |
| Price To Sales Ratio | 563.96 | - | - | - | - | - |
| Gross Margin | 13.67 | 36.90 | 39.41 | 37.01 | 27.51 | 38.59 |
| Operating Margin | -33.57 | 12.67 | 19.81 | 11.49 | 5.83 | 17.02 |
| Net Margin | -7.78 | 8.66 | 14.64 | 7.67 | 4.82 | 8.89 |
| Shares Outstanding | 11.55 | 11.25 | 11.25 | 10.00 | 11.25 | 10.00 |
| Market Capitalization | 29.68 | 35.89 | - | - | - | - |
Balance sheet, annual
| Metric | 2025FY | 2024FY | 2023FY | 2022FY |
|---|---|---|---|---|
| Cash & Short Term Investments | 0.04 | 0.02 | 0.03 | 0.04 |
| Short Term Receivables | 0.01 | 0.02 | 0.01 | 0.03 |
| Inventories | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Current Assets | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Current Assets | 0.05 | 0.04 | 0.04 | 0.07 |
| Net Property, Plant & Equipment | 0.04 | 0.04 | 0.06 | 0.07 |
| Total Investments and Advances | 0.00 | 0.00 | 0.00 | 0.00 |
| Intangible Assets | 0.01 | 0.01 | 0.01 | 0.00 |
| Deferred Tax Assets | 0.01 | 0.01 | 0.01 | 0.01 |
| Other Assets | 0.00 | 0.01 | 0.01 | 0.00 |
| Total Assets | 0.11 | 0.10 | 0.13 | 0.16 |
| Short Term Debt Incl. Current Port. of LT Debt | 0.01 | 0.01 | 0.02 | 0.03 |
| Accounts Payable | 0.00 | 0.01 | 0.00 | 0.01 |
| Income Tax Payable | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Current Liabilities | 0.00 | 0.01 | 0.00 | 0.01 |
| Total Current Liabilities | 0.02 | 0.03 | 0.03 | 0.05 |
| Long Term Debt | 0.05 | 0.05 | 0.08 | 0.10 |
| Provision for Risks Charges | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax Liabilities | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Liabilities | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Liabilities | 0.07 | 0.09 | 0.12 | 0.15 |
| Non-Equity Reserves | 0.00 | 0.00 | 0.00 | 0.00 |
| Preferred Stock - Carrying Value | 0.00 | 0.00 | 0.00 | 0.00 |
| Common Equity | 0.04 | 0.02 | 0.01 | 0.01 |
| Total Shareholders Equity | 0.04 | 0.02 | 0.01 | 0.01 |
| Accumulated Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Equity | 0.04 | 0.02 | 0.01 | 0.01 |
| Total Liabilities & Stockholders Equity | 0.11 | 0.10 | 0.13 | 0.16 |
| Book Value Per Share | 0.00 | 0.00 | 0.00 | 0.00 |
| Tangible Book Value Per Share | 0.00 | 0.00 | -0.00 | 0.00 |
| Full-Time Employees | 313 | 323 | - | 353 |
| Price to Book Ratio | 774.48 | 1,611.11 | - | - |
| Return on Assets | 0.75 | 7.60 | 3.82 | - |
| Return on Equity | 2.91 | 67.97 | 73.65 | - |
| Return on Invested Capital | 0.93 | 12.65 | 6.11 | -3.26 |
| Quick Ratio | 2.68 | 1.20 | 1.25 | 1.55 |
| Current Ratio | 2.70 | 1.21 | 1.27 | 1.55 |
Cash flow, annual
| Metric | TTM | 2025FY | 2024FY | 2023FY | 2022FY |
|---|---|---|---|---|---|
| Net Income | - | 0.00 | 0.01 | 0.01 | -0.00 |
| Depreciation | - | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Taxes & Investment Tax Credit | - | -0.00 | 0.00 | 0.00 | -0.00 |
| Other Funds (Non Cash) | - | 0.01 | 0.00 | 0.01 | 0.01 |
| Funds from Operations | - | 0.01 | 0.02 | 0.02 | 0.01 |
| Extraordinary Item | - | 0.00 | 0.00 | 0.00 | 0.00 |
| Changes in Working Capital | - | -0.01 | -0.01 | -0.02 | -0.00 |
| Income Taxes Payable | - | -0.00 | 0.00 | 0.00 | 0.00 |
| Cash from Operating Activities | - | 0.01 | 0.01 | 0.00 | 0.01 |
| Capital Expenditures | - | -0.00 | -0.00 | -0.01 | -0.00 |
| Net Assets From Acquisitions | - | 0.00 | 0.00 | 0.00 | -0.00 |
| Sale of Fixed Assets and Businesses | - | 0.00 | 0.00 | 0.00 | 0.00 |
| Purchase or Sale of Investments | - | 0.00 | 0.00 | 0.00 | 0.00 |
| Purchase of Investments | - | 0.00 | 0.00 | 0.00 | 0.00 |
| Sale Or Maturity of Investments | - | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Uses | - | 0.00 | 0.00 | 0.00 | -0.02 |
| Other Sources | - | 0.00 | 0.00 | 0.02 | 0.01 |
| Cash from Investing Activities | - | -0.00 | -0.00 | 0.00 | -0.01 |
| Cash Dividends Paid | - | 0.00 | 0.00 | 0.00 | 0.00 |
| Preferred Dividends (Cash Flow) | - | 0.00 | 0.00 | 0.00 | 0.00 |
| Change in Capital Stock | - | 0.03 | 0.00 | 0.00 | 0.00 |
| Repurchase of Common Pref Stock | - | 0.00 | 0.00 | 0.00 | 0.00 |
| Sale of Common Pref Stock | - | 0.03 | 0.00 | 0.00 | 0.00 |
| Proceedsfrom Stock Options | - | 0.03 | 0.00 | 0.00 | 0.00 |
| Issuance or Reduction of Debt, Net | - | -0.01 | -0.01 | -0.00 | -0.00 |
| Change in Long Term Debt | - | -0.01 | -0.00 | -0.00 | -0.00 |
| Issuance of Long Term Debt | - | 0.00 | 0.00 | 0.00 | 0.00 |
| Reduction of Long Term Debt | - | -0.01 | -0.00 | -0.01 | -0.00 |
| Net Financing Active Other Cash Flow | - | -0.00 | -0.00 | -0.00 | 0.00 |
| Other Financing Activities Uses | - | -0.00 | -0.00 | -0.00 | 0.00 |
| Cash from Financing Activities | - | 0.02 | -0.02 | -0.01 | -0.00 |
| Exchange Rate Effect | - | -0.00 | -0.00 | -0.00 | -0.01 |
| Net Change in Cash | - | 0.02 | -0.01 | -0.00 | -0.01 |
| Free Cash Flow | - | 0.00 | 0.00 | 0.00 | 0.01 |
| Price to Free Cash Flow | - | 7,658.15 | - | - | - |
Balance sheet, quarterly
| Metric | 2025S2 | 2025S1 | 2024S2 | 2024S1 | 2023S2 | 2023S1 |
|---|---|---|---|---|---|---|
| Cash & Short Term Investments | 0.04 | 0.02 | 0.02 | 0.03 | 0.03 | - |
| Short Term Receivables | 0.01 | 0.01 | 0.02 | 0.01 | 0.01 | - |
| Inventories | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | - |
| Other Current Assets | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | - |
| Total Current Assets | 0.05 | 0.03 | 0.04 | 0.03 | 0.04 | - |
| Net Property, Plant & Equipment | 0.04 | 0.05 | 0.04 | 0.04 | 0.06 | - |
| Total Investments and Advances | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | - |
| Intangible Assets | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | - |
| Deferred Tax Assets | 0.01 | 0.01 | 0.01 | 0.00 | 0.01 | - |
| Other Assets | 0.00 | 0.01 | 0.01 | 0.01 | 0.01 | - |
| Total Assets | 0.11 | 0.11 | 0.10 | 0.10 | 0.13 | - |
| Short Term Debt Incl. Current Port. of LT Debt | 0.01 | 0.01 | 0.01 | 0.02 | 0.02 | - |
| Accounts Payable | 0.01 | 0.01 | 0.01 | 0.00 | 0.00 | - |
| Income Tax Payable | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | - |
| Other Current Liabilities | 0.00 | 0.00 | 0.01 | 0.00 | 0.00 | - |
| Total Current Liabilities | 0.02 | 0.02 | 0.03 | 0.03 | 0.03 | - |
| Long Term Debt | 0.05 | 0.06 | 0.05 | 0.05 | 0.08 | - |
| Deferred Tax Liabilities | 0.00 | - | 0.00 | - | 0.00 | - |
| Other Liabilities | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | - |
| Total Liabilities | 0.07 | 0.09 | 0.09 | 0.09 | 0.12 | - |
| Non-Equity Reserves | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | - |
| Preferred Stock - Carrying Value | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | - |
| Common Equity | 0.04 | 0.02 | 0.02 | 0.01 | 0.01 | - |
| Total Shareholders Equity | 0.04 | 0.02 | 0.02 | 0.01 | 0.01 | - |
| Accumulated Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | - |
| Total Equity | 0.04 | 0.02 | 0.02 | 0.01 | 0.01 | - |
| Total Liabilities & Stockholders Equity | 0.11 | 0.11 | 0.10 | 0.10 | 0.13 | - |
| Book Value Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | - |
| Tangible Book Value Per Share | 0.00 | 0.00 | 0.00 | -0.00 | -0.00 | - |
| Price to Book Ratio | 762.61 | 1,611.11 | - | - | - | - |
| Return on Assets | 0.79 | 9.04 | 7.61 | - | - | - |
| Return on Equity | 3.05 | 57.18 | 68.09 | - | - | - |
| Return on Invested Capital | -2.51 | 3.62 | 8.91 | 4.16 | 1.84 | - |
| Quick Ratio | 2.68 | 1.44 | 1.20 | 1.11 | 1.25 | - |
| Current Ratio | 2.70 | 1.47 | 1.21 | 1.12 | 1.27 | - |
Cash flow, quarterly
| Metric | 2025S2 | 2025S1 | 2024S2 | 2024S1 | 2023S2 | 2023S1 |
|---|---|---|---|---|---|---|
| Net Income | - | - | 0.01 | 0.00 | 0.00 | 0.00 |
| Depreciation | - | - | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Funds (Non Cash) | - | - | 0.00 | 0.00 | 0.00 | 0.01 |
| Funds from Operations | - | - | 0.01 | 0.01 | 0.00 | 0.01 |
| Extraordinary Item | - | - | 0.00 | 0.00 | 0.00 | 0.00 |
| Changes in Working Capital | - | - | -0.01 | -0.00 | 0.00 | -0.02 |
| Income Taxes Payable | - | - | 0.00 | -0.00 | 0.00 | 0.00 |
| Cash from Operating Activities | - | - | 0.00 | 0.00 | 0.01 | -0.00 |
| Capital Expenditures | - | - | -0.00 | -0.00 | -0.01 | -0.00 |
| Net Assets From Acquisitions | - | - | 0.00 | 0.00 | 0.00 | 0.00 |
| Sale of Fixed Assets and Businesses | - | - | 0.00 | 0.00 | -0.00 | 0.00 |
| Purchase or Sale of Investments | - | - | 0.00 | 0.00 | 0.00 | 0.00 |
| Purchase of Investments | - | - | 0.00 | 0.00 | 0.00 | 0.00 |
| Sale Or Maturity of Investments | - | - | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Uses | - | - | 0.00 | 0.00 | 0.02 | -0.02 |
| Other Sources | - | - | 0.00 | 0.00 | -0.00 | 0.02 |
| Cash from Investing Activities | - | - | -0.00 | -0.00 | 0.00 | 0.00 |
| Cash Dividends Paid | - | - | 0.00 | 0.00 | 0.00 | 0.00 |
| Preferred Dividends (Cash Flow) | - | - | 0.00 | 0.00 | 0.00 | 0.00 |
| Change in Capital Stock | - | - | 0.00 | 0.00 | 0.00 | 0.00 |
| Repurchase of Common Pref Stock | - | - | 0.00 | 0.00 | 0.00 | 0.00 |
| Sale of Common Pref Stock | - | - | 0.00 | 0.00 | 0.00 | 0.00 |
| Proceedsfrom Stock Options | - | - | 0.00 | 0.00 | 0.00 | 0.00 |
| Issuance or Reduction of Debt, Net | - | - | -0.01 | -0.00 | -0.00 | -0.00 |
| Change in Long Term Debt | - | - | -0.00 | -0.00 | -0.00 | -0.00 |
| Issuance of Long Term Debt | - | - | 0.00 | 0.00 | 0.00 | 0.00 |
| Reduction of Long Term Debt | - | - | -0.00 | -0.00 | -0.00 | -0.00 |
| Net Financing Active Other Cash Flow | - | - | -0.00 | -0.00 | -0.00 | -0.00 |
| Other Financing Activities Uses | - | - | -0.00 | -0.00 | -0.00 | -0.00 |
| Cash from Financing Activities | - | - | -0.01 | -0.00 | -0.01 | -0.00 |
| Exchange Rate Effect | - | - | 0.00 | -0.00 | 0.00 | -0.00 |
| Net Change in Cash | - | - | -0.01 | -0.00 | 0.00 | -0.01 |
| Free Cash Flow | - | - | 0.00 | 0.00 | 0.01 | -0.00 |
Revenue breakdown
| Japan | 2024: 11.58M 2025: 9.34M |
|---|
Short interest
shares short against float, oldest to newest| Settlement | Of float | Shares short | Float | Avg volume |
|---|---|---|---|---|
| 2026-10-30 | 0.52% | 0.0M | 2.3M | 88.73K |
| 2026-10-15 | 1.22% | 0.0M | 2.3M | 91.30K |
| 2026-09-30 | 1.01% | 0.0M | 2.3M | 87.71K |
| 2026-09-15 | 1.72% | 0.0M | 2.3M | 260.50K |
| 2026-08-31 | 1.57% | 0.0M | 2.3M | 276.74K |
| 2026-08-14 | 1.09% | 0.0M | 2.3M | 1.18M |
| 2026-07-31 | 1.87% | 0.0M | 2.3M | 1.17M |
| 2026-07-15 | 2.86% | 0.1M | 2.3M | 1.18M |
| 2026-06-30 | 12.84% | 0.3M | 2.3M | 1.13M |
| 2026-06-15 | 3.40% | 0.1M | 2.3M | 945.70K |
| 2026-05-29 | 5.52% | 0.1M | 2.3M | 944.37K |
| 2026-05-15 | 0.04% | 0.0M | 2.3M | 18.72K |
| 2026-04-30 | 0.08% | 0.0M | 2.3M | 16.60K |
| 2026-04-15 | 0.05% | 0.0M | 2.3M | 18.49K |
| 2026-03-31 | 0.05% | 0.0M | 2.7M | 21.42K |
| 2026-03-13 | 0.40% | 0.0M | 2.6M | 22.64K |
| 2026-02-27 | 0.50% | 0.0M | 2.6M | 28.82K |
| 2026-02-13 | 0.59% | 0.0M | 2.6M | 31.62K |
| 2026-01-30 | 0.80% | 0.0M | 2.6M | 39.56K |
| 2026-01-15 | 0.59% | 0.0M | 2.6M | 915.79K |
Option chain
expiry 2026-11-11| Type | Strike | Bid | Ask | Last | IV | Open int | Volume | Delta | Theta | Vega |
|---|---|---|---|---|---|---|---|---|---|---|
| No option chain for this symbol. | ||||||||||
Latest SEC filings
30| Filed | Form | Description | Period | Link |
|---|---|---|---|---|
| 2026-10-15 | 6-K | Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 | 2026-10-15 | SEC |
| 2026-06-15 | 6-K | Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 | 2026-06-15 | SEC |
| 2026-04-14 | 6-K | Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 | 2026-04-13 | SEC |
| 2026-04-08 | 20-F/A | 2025-12-31 | SEC | |
| 2026-03-30 | 6-K | Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 | 2026-03-30 | SEC |
| 2026-03-23 | 20-F | Registration statement under Section 12 of the Securities Exchange Act of 1934 or an annual or transition report filed under Section 13(a) or 15(d) of the Exchange Act for a foreign private issuer. | 2025-12-31 | SEC |
| 2026-03-18 | 3 | Initial statement of beneficial ownership of securities | 2026-03-18 | SEC |
| 2026-03-18 | 3 | Initial statement of beneficial ownership of securities | 2026-03-18 | SEC |
| 2026-03-18 | 3 | Initial statement of beneficial ownership of securities | 2026-03-18 | SEC |
| 2026-03-18 | 3 | Initial statement of beneficial ownership of securities | 2026-03-18 | SEC |
| 2026-03-18 | 3 | Initial statement of beneficial ownership of securities | 2026-03-18 | SEC |
| 2026-03-18 | 3 | Initial statement of beneficial ownership of securities | 2026-03-18 | SEC |
| 2026-03-04 | 6-K | Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 | 2026-03-04 | SEC |
| 2026-03-02 | 6-K | Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 | 2026-03-02 | SEC |
| 2025-12-15 | 6-K | Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 | 2025-12-15 | SEC |
| 2025-12-02 | 6-K | Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 | 2025-12-02 | SEC |
| 2025-11-12 | 6-K | Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 | 2025-11-12 | SEC |
| 2025-10-24 | 6-K | Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 | 2025-10-24 | SEC |
| 2025-10-21 | 6-K | Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 | 2025-10-21 | SEC |
| 2025-09-18 | 6-K | Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 | 2025-09-18 | SEC |
| 2025-09-05 | 6-K | Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 | 2025-09-05 | SEC |
| 2025-08-20 | SCHEDULE 13D | SEC | ||
| 2025-08-20 | SCHEDULE 13D | SEC | ||
| 2025-08-15 | 6-K | Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 | 2025-08-15 | SEC |
| 2025-08-15 | 6-K | Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 | 2025-08-15 | SEC |
| 2025-08-14 | 424B4 | SEC | ||
| 2025-08-08 | CERT | SEC | ||
| 2025-08-04 | 8-A12B | SEC | ||
| 2025-07-31 | EFFECT | Effectiveness filing by commission order | SEC | |
| 2025-07-29 | CORRESP | SEC |
Insider activity by month
| Month | Bought | Buys | Sold | Sells |
|---|---|---|---|---|
| 2026-11 | 0 | 0 | 0 | 0 |
| 2026-10 | 0 | 0 | 0 | 0 |
| 2026-09 | 0 | 0 | 0 | 0 |
| 2026-08 | 0 | 0 | 0 | 0 |
| 2026-07 | 0 | 0 | 0 | 0 |
| 2026-06 | 0 | 0 | 0 | 0 |
| 2026-05 | 0 | 0 | 0 | 0 |
| 2026-04 | 0 | 0 | 0 | 0 |
| 2026-03 | 0 | 0 | 0 | 0 |
| 2026-02 | 0 | 0 | 0 | 0 |
| 2026-01 | 0 | 0 | 0 | 0 |
| 2025-12 | 0 | 0 | 0 | 0 |
| 2025-11 | 0 | 0 | 0 | 0 |
Institutional holders
| Manager | % owned |
|---|---|
| UBS Group AG | 0.02% |
| JPMORGAN CHASE & CO | 0.00% |
| Caitong International Asset Management Co., Ltd | 0.00% |
Funds
| Fund | % owned |
|---|---|
| Fidelity Nasdaq Composite Index Fund | 0.06% |
OakChart. RYOJ. Cached 15 minutes.
Some panels did not load: ratings, insider, news.